SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunityBio converts from Immunomedics
IBRX 2.580-3.0%Oct 28 3:59 PM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: luckydog88 who wrote (1198)10/22/2025 9:54:43 AM
From: dorightbythem4 Recommendations

Recommended By
bobbseytwins2001
erippetoe
jargonweary
luckydog88

  Read Replies (2) of 1216
 
First comes the hype, followed by self promotion without any trials or data to back up the assertions.
Then comes the corporate statements showing that no individual’s shareholders or groups of shareholders other than PSS haven’t got enough shares in order to determine whether additional debt taken on by the company can be challenged. All before sales are announced and overseas approvals are completed.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News